Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer
Open Access
- 1 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 17 (1) , 232-240
Abstract
Inflammatory bowel disease (IBD) exposes patients to an increased risk of colorectal cancer (i-CRC) and differences between i-CRC and sporadic colorectal cancer (s-CRC) pathogenesis were reported. In s-CRC, studies indicate abnormalities in the tumor-suppressor gene Cdx2. This study compared CDX2, β-catenin, and TP53 expression in i-CRC, s-CRC, noncancer IBD, and normal control colonic mucosa. Expression was investigated by immunohistochemistry in 10 normal, 20 s-CRC, 11 noncancer colonic IBD and 30 i-CRC samples, and in four samples of Crohn's disease (CD)-associated small bowel adenocarcinoma (i-SBA). In normal and noncancer IBD samples, CDX2 was confined to the colonocytes nuclei. CDX2 expression was normal in 90% of i-CRC, regardless of tumor differentiation or inflammation intensity. By contrast, CDX2 expression was altered in 45% s-CRC, particularly at the front of invasion in undifferentiated tumors. β-Catenin was restricted to cell membrane in all controls, in 91% noncancer IBD, and in 84% i-CRC samples, whereas 35% s-CRC showed cytoplasmic redistribution and exclusive nuclear staining at the front of invasion. TP53 was strongly and homogeneously expressed in i-CRC nuclei compared to normal control or s-CRC, and increases with inflammation intensity. Nested or diffuse TP53 was found in 81.8% of noncancer IBD samples with a higher proportion of TP53-expressing cells in the most inflamed samples. CDX2, β-catenin, and TP53 expression in CD-associated SBA appears similar to that of i-CRC. Neither Cdx2 nor β-catenin alterations are prominent features of i-CRC. In i-CRC and CD-associated SBA, carcinogenesis is associated early with p53 mutations and to inflammation intensity.Keywords
This publication has 49 references indexed in Scilit:
- Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal CancerClinical Cancer Research, 2009
- Establishment of Intestinal Identity and Epithelial-Mesenchymal Signaling by Cdx2Developmental Cell, 2009
- Tumor formation due to abnormalities in the β‐catenin‐independent pathway of Wnt signalingCancer Science, 2008
- Expression of Mucins, SIMA, Villin, and CDX2 in Small-Intestinal AdenocarcinomaAmerican Journal of Clinical Pathology, 2007
- Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort StudyGastroenterology, 2007
- p53 Mutations are Associated with Dysplasia and Progression of Dysplasia in Patients with Crohn’s DiseaseDigestive Diseases and Sciences, 2007
- Different effects of the Cdx1 and Cdx2 homeobox genes in a murine model of intestinal inflammationGut, 2007
- Cyclooxygenase-2 and Colorectal Cancer Chemoprevention: The β-Catenin ConnectionCancer Research, 2006
- Molecular Biology of Dysplasia and Cancer in Inflammatory Bowel DiseaseGastroenterology Clinics of North America, 2006
- Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: a comparison with colorectal adenocarcinomaLaboratory Investigation, 2006